This content is from: Premium
EcoR1 Capital Looks to Cash in on Two IPOs
The biotech specialist is riding the biopharma IPO boom.
Hedge fund firm EcoR1 Capital is gearing up for two privately-held biopharma companies in its portfolio to go public. Both of these companies recently registered to go public. One of them earlier this week set the general terms for its offering.The two companies are among the latest in a spate of
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.